10.12.2020 • NewsAxensCargill

Axens, Cargill and IFPEN Link on Bio-Acrylic acid

French technology company Axens, its parent company IFP Energies nouvelles (IFPEN), and US food and agricultural giant Cargill are joining forces to further develop and scale bio-based acrylic acid.

The partners aim to commercialize lactic-to-acrylic-acid technology that Procter & Gamble has been developing in its laboratories and which it licensed to Cargill in May.

“By leveraging Cargill’s processing technology and IFPEN/Axens’ know-how in catalysis and scale up, we’re aiming to produce acrylic acid from renewable sources thereby reducing greenhouse gas emissions by more than 50 percent,” said Jill Zullo, vice president of bio-intermediates in Cargill’s bio-industrial business. She added that more than 6 million t of fossil-based acrylic acid will be produced this year.

Efforts will focus on the catalyst and process development needed to convert lactic acid into bio-based acrylic acid at scale. Acrylic acid is used in various applications, from hygiene products to household paints.

The companies will advance the technology according to staged milestones. Although it will be several years before it is ready to be deployed at commercial scale, they said test samples could be ready for potential customers sometime within the next 12 months. 

Author: Elaine Burridge, Freelance Journalist

Axens, IFP Energies nouvelles and Cargill are linking to further develop and...
Axens, IFP Energies nouvelles and Cargill are linking to further develop and scale bio-based acrylic acid. The partners aim to commercialize lactic-to-acrylic-acid technology that Procter & Gamble has been developing in its laboratories and which it licensed to Cargill in May. (c) PilMo Kang

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.